FDA inspection
Amplion Clinical Communications, Inc.: FDA inspection ending Nov 4, 2013
FDA inspection 854307 · Official Action Indicated (OAI) · Nashville, TN
Key facts
| Inspection ID | 854307 |
|---|---|
| Firm | Amplion Clinical Communications, Inc. |
| FEI number | 3009164985 |
| Address | 632 Melrose Ave |
| City | Nashville |
| State | TN |
| ZIP | 37211 |
| Country | United States |
| Fiscal year | 2014 |
| Inspection end date | Nov 4, 2013 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
| Warning letter | 416695 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data